Related Experiment Video
Updated: May 18, 2026
07:32
In vitro Induction of Human Dental Pulp Stem Cells Toward Pancreatic Lineages
Published on: September 25, 2021
Induced pluripotent stem cell technology and stem cell therapy for diabetes
Robert J Drummond1, Tilo Kunath, P Joseph Mee
1Tissue Injury and Repair Group, MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, Scotland EH16 4SB;
Experimental and Therapeutic Medicine
|September 15, 2012
Summary
Diabetes management with insulin is inconvenient and incurable. Stem cell therapy offers potential for cell replacement, but more research is needed on diabetes biology for successful transplantation.
Area of Science:
- Regenerative Medicine
- Endocrinology
- Stem Cell Biology
Background:
- Diabetes mellitus is a chronic, incurable endocrine disorder requiring lifelong management, often with insulin injections.
- Long-term diabetes complications include cardiovascular disease, highlighting the need for alternative treatments.
- Current treatments manage symptoms but do not restore normal physiological function or cure the disease.
Purpose of the Study:
- To explore the potential of stem cell-based therapies for treating diabetes.
- To investigate the use of induced pluripotent stem cells for generating insulin-producing cells for transplantation.
- To identify key biological factors in diabetes onset that need further understanding for therapeutic development.
Main Methods:
- Review of current stem cell technologies, focusing on induced pluripotent stem cells (iPSCs).
- Analysis of the differentiation potential of stem cells into various tissue lineages, including pancreatic beta cells.
- Examination of the biological mechanisms underlying diabetes development.
Main Results:
- Stem cells, particularly iPSCs, demonstrate the capacity to differentiate into diverse cell types.
- This differentiation potential offers a promising route for generating functional cells for transplantation.
- Significant gaps in understanding diabetes pathogenesis remain, posing challenges for cell therapy.
Conclusions:
- Stem cell-based therapies hold promise for a potential cure for diabetes by replacing defective cells.
- Further research into the fundamental biology of diabetes is crucial for advancing cell replacement strategies.
- Overcoming biological hurdles is essential before stem cell treatments can become a clinical reality for diabetes patients.
Related Concept Videos
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...